COOPER HEALTH SYSTEM
8Patents
7Active
8Granted
45Portfolio score
Filing activity: Oct 2, 2003 → Jan 11, 2021 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9650352B2 | Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain | Chemistry; Metallurgy | 19 | Active |
| US7931594B2 | Regional anesthetic method and apparatus | Human Necessities | 11 | Active |
| US8479739B2 | System and method for managing difficult airways | Human Necessities | 11 | Active |
| US7645238B2 | Regional anesthetic method and apparatus | Human Necessities | 9 | Active |
| US9867830B2 | Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain | Chemistry; Metallurgy | 9 | Active |
| US10085665B2 | Non-invasive system and method for monitoring lusitropic myocardial function in relation to inotropic myocardial function | Emerging Cross-Sectional Technologies | 1 | Active |
| US7528172B2 | Compositions and methods for improving recovery after general anesthesia | Human Necessities | 0 | Expired |
| US11547341B2 | Non-invasive system and method for monitoring lusitropic myocardial function in relation to inotropic myocardial function | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.